|Year : 2019 | Volume
| Issue : 2 | Page : 100-104
The relation between insulin resistance and left ventricular mass in hypertensive nondiabetic patients
Ahmed Shawky Shereef, Nader Talat Kandeel
Department of Cardiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
|Date of Web Publication||23-Sep-2019|
Dr. Ahmed Shawky Shereef
Department of Cardiology, Faculty of Medicine, Zagazig University, Zagazig
Source of Support: None, Conflict of Interest: None
Background: Patients with essential hypertension (EH) are often associated with left ventricular (LV) hypertrophy (LVH) and insulin resistance (IR). Insulin may have a direct growth-promoting effect on cardiomyocytes. Hence, the aim of this work was to study the effect of IR on LV geometry in newly diagnosed arterial hypertensive nondiabetic patients not taking any antihypertensive medication. Methods: One hundred and eight patients were included in our study including 88 newly diagnosed hypertensive nondiabetic patients and 20 healthy controls. Fasting glucose, insulin levels, total cholesterol, high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol, and triglyceride levels were measured. Homeostasis Model Assessment (HOMA) index was calculated for the assessment of IR. Echocardiography measurements of LV dimensions such as LV mass (LVM) and LVM index (LVMI) were calculated. Results: Fasting blood insulin and HOMA index were significantly higher in patients with LVH than patients with normal LV dimensions and controls. We found highly significant positive correlations between insulin levels, LVM, and LVMI. In addition, we found highly significant positive correlations between HOMA index, LVM, and LVMI. Conclusion: We conclude that cardiac changes in hypertensive patients including those with increased wall thickness, LVM, and LVMI are mediated, at least in part, by increased insulin levels and the HOMA index.
Keywords: Homeostasis Model Assessment index, hypertension, insulin resistance, left ventricular hypertrophy
|How to cite this article:|
Shereef AS, Kandeel NT. The relation between insulin resistance and left ventricular mass in hypertensive nondiabetic patients. J Indian coll cardiol 2019;9:100-4
|How to cite this URL:|
Shereef AS, Kandeel NT. The relation between insulin resistance and left ventricular mass in hypertensive nondiabetic patients. J Indian coll cardiol [serial online] 2019 [cited 2020 Jan 25];9:100-4. Available from: http://www.joicc.org/text.asp?2019/9/2/100/267492
| Introduction|| |
Both left ventricular (LV) hypertrophy (LVH) and hyperinsulinemia/insulin resistance (IR) are known independent cardiovascular risk factors., A wide variety of LV geometry has been found in general population samples and in patients with essential hypertension (EH).
In obese patients, arterial hypertension contributes significantly to LV diastolic dysfunction before detecting structural changes by echocardiography.
Hypertension is an essential stimulus for the development of LVH. However, LV mass (LVM) increases in some hypertensive patients, whereas it remains within normal limits in others. On the other hand, some nonhemodynamic factors such as genetic, environmental, and metabolic factors have also been suggested to affect LVM and geometry.,
The metabolic factors include the presence of IR which has been found to be associated with LV growth. Homeostasis Model Assessment (HOMA) is a method that allows an easy and inexpensive assessment of IR.
| Aim of the Work|| |
The aim of the work was to examine the effect of IR on LV geometry in newly diagnosed arterial hypertensive (NDAH) nondiabetic patients not taking any antihypertensive medication.
| Methods|| |
This study had been carried out in the Cardiology Department of Zagazig University Hospitals during the period between January, 2016, and August, 2017.
One hundred and eight patients (66 males and 42 females) with a mean age of 48.9 ± 4.67 years were enrolled in the study including 88 newly diagnosed hypertensive patients (54 males and 34 females) and 20 healthy controls.
All the patients were newly diagnosed hypertensive patients. Hypertension was defined as elevation of blood pressure ≥140 mmHg for systolic and/or ≥90 mmHg for diastolic blood pressure as the mean of three different measurements in at least three different visits at 1-week interval.
Exclusion criteria were a family history of diabetes, obesity (body mass index must be <30 kg/m2), coronary artery disease, congestive heart failure, valvular heart disease, impaired glucose tolerance, and diabetes mellitus. All patients were free from cardiac medications and drugs known to interfere with glucose metabolism.
Blood samples were taken after 10 h of overnight fasting to measure both fasting glucose and insulin levels. Fasting insulin concentrations were measured by radioimmunoassay. In the same sitting, serum samples were withdrawn to determine fasting total cholesterol, high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), and triglyceride levels. HOMA was calculated for the assessment of IR. The HOMA index was calculated according to the formula developed by Matthews, et al. as follows:
Fasting blood glucose (mg/dl) × fasting insulin (μ/ml)/405
Echocardiographic studies were performed on each patient using a commercially available Hewlett Packard 5500 (HP 5500, Sonos 5500, Boston, MA, USA) echo-set using a 2.5 MHz transducer. Two-dimensional guided M-mode measurements of LV end-diastolic dimension (LVEDD), interventricular septum thickness (IVST), posterior wall thickness (PWT), left atrial diameter, fraction of shortening (FS), and ejection fraction were performed as recommended by the American Society of Echocardiography.
LVM was calculated according to the equation of Devereux et al. as follows:
0.80× ([1.04× [LVEDD + IVST + PWT] 3 – [LVEDD] 3) +0.6 g
LVM was indexed by body surface area; LVH was defined as an LVM index (LVMI) of 125 g/m2 in men and 110 g/m2 in women.
According to LVMI, hypertensive patients were classified into two groups: normal and LVH. Hence, we had the following three groups in our study:
- Hypertensive patients with normal LV dimensions: this group included 46 patients (28 males and 18 females) with a mean age of 48.6 ± 3.55 years
- Hypertensive patients with LVH: this group included 42 patients (26 males and 16 females) with a mean age of 49.8 ± 3.72 years
- Healthy controls: This group included 20 controls (12 males and 8 females) with a mean age of 47.7 ± 7.74 years.
All statistics were analyzed using the SPSS (SPSS 11.0 for windows Student version) 11.5 package program. Differences among the study groups were analyzed by Student's t-test and Chi-square test. The correlations among the HOMA index, insulin levels, and LV measurements were investigated by Pearson's correlation analysis. P <0.05 was regarded as being statistically significant.
| Results|| |
We enrolled 108 individuals (66 females and 42 males) in this study; among them, 20 were healthy controls and 88 were patients with untreated newly diagnosed mild-to-moderate hypertension (151.5 ± 5.37 mmHg for systolic and 97.8 ± 3.78 mmHg for diastolic blood pressure).
As shown in [Table 1], there was no significant difference among the study groups concerning the clinical data, except for a highly significantly systolic and diastolic blood pressure in normal and LVH groups than control group.
Metabolic data are shown in [Table 2]. Fasting blood insulin and HOMA index were significantly higher in patients with LVH than in patients with normal LV dimensions and controls. Other metabolic data showed no significant difference among the study groups.
Echocardiographic data are shown in [Table 3]. As shown, PWT, IVST, LVM, and LVMI were significantly higher in patients with LVH than in patients with normal LV dimensions and controls. Other measures showed no significant difference among the study groups.
Pearson's correlation analysis performed among the insulin levels and echocardiographic measurements showed highly significant positive correlations between insulin levels and IVS (r = 0.35, P = 0.00083), PWT (r = 0.338, P = 0.00128), LVM (r = 0.367, P = 0.00044), and LVMI (r = 0.374, P = 0.00033), as shown in [Table 4].
|Table 4: Correlation analysis between insulin, Homeostasis Model Assessment index, and echocardiographic parameters|
Click here to view
Again, Pearson's correlation analysis was performed among the HOMA index and echocardiographic measurements, which revealed highly significant positive correlations with IVS (r = 0.759, P < 0.00001), PWT (r = 0.783, P < 0.00001), LVM (r = 0.702, P < 0.00001), and LVMI (r = 0.79, P < 0.00001) as shown in [Table 4].
Correlations of HOMA index with LVM and LVMI are shown in [Figure 1]a and [Figure 1]b.
|Figure 1: (a and b) Correlation of Homeostasis Model Assessment-index with left ventricular mass and left ventricular mass index|
Click here to view
There was no significant correlation between insulin level or HOMA index and other echocardiographic parameters.
| Discussion|| |
Both LVH and hyperinsulinemia/IR are known independent risk factors for cardiovascular diseases, and have often been found in patients with EH. A wide variety of LV geometry has been found in general population samples and in patients with EH.
Our study confirms that there is an association between insulin action and degree of LVM and also shows that patients with a normal LV pattern have a significantly better insulin action (lower fasting insulin levels and lower HOMA index) compared with those with abnormal LV geometry. Our study also shows significant positive correlations between IVST, PWT, LVM, LVMI (echocardiographic parameters of LVH), and IR, measured with fasting plasma insulin levels and the HOMA index (which is an IR parameter) in hypertensive patients.
There was no significant correlation between insulin level or HOMA index and LVEDD.
The correlations between measures of IR and LV structure have been studied in different populations with varying results. Significant relationships between IR and LVM have been reported in hypertensive populations.
However, other investigators have only found a weak correlation between these parameters or no association at all after adjustments for covariates.
Furthermore, a change in the echocardiographic patterns from normal to concentric hypertrophy, including concentric remodeling, is associated with a trend toward IR.
Previous studies have concluded that LVH has a bad prognosis for hypertension. In fact, patients with increased LVM have a greater risk of cardiovascular and all-cause mortality than those with lower LVM. Krumholz et al. have demonstrated a high risk of cardiovascular adverse events in patients with concentric LVH and a low risk in those with normal LV geometry, and this difference widened progressively over a 10-year follow-up, despite conventional antihypertensive therapy.
Epidemiological studies have shown that high fasting insulin levels are associated with an adverse cardiovascular outcome, independent of other risk factors, and this could be explained in part by a remodeling effect by insulin on LV structure.
It has been proposed that insulin may affect cardiac geometry by acting as a growth-promoting factor, and its trophic effects on myocardial tissue have been demonstrated in cell cultures and animal models.
Moreover, it has been suggested that hyperinsulinemia stimulates sympathetic nervous system (SNS) activity which may affect ventricular structure directly due to growth-stimulating effects, or, indirectly, by the increment in both heart rate and blood pressure levels.
Such data support the hypothesis that the reason for the increase in wall thickness, which is a sign of myocardial structural change, and in part LVH itself in hypertensive patients, might be the increased fasting insulin levels and HOMA index, which is an indicator of IR. Many pathophysiologic factors could be behind such an association, and an insulin-mediated overdrive in SNS activity should be considered.
Kaftan et al. found that the positive correlation between insulin levels and the HOMA index was substantially stronger with the sum of wall thickness and relative wall thickness than the LVMI, and they concluded that insulin acts through increases in wall thicknesses, rather than an increase in LVED during the LV geometric change process in hypertensive patients, although recent studies reported that abnormalities of LV filling precede detectable structural changes and impairment of systolic function. They are considered one of the earliest signs of cardiac involvement in the presence of different cardiovascular risk factors. NDAH also plays an important role in LV diastolic dysfunction pathogenesis.
Another hypothesis is SNS overdrive is responsible for both IR and development of LVH. In fact, hypertensive patients with LVH had higher plasma catecholamine concentrations than hypertensive patients without LVH and controls.
On the other hand, our findings suggest that IR exerts its influence directly on myocardial walls, independently of LVED. Hyperinsulinemia might increase LVM through its growth-stimulating effect. In fact, insulin can bind and activate the insulin-like growth factor-1 receptor, leading to increased DNA and protein synthesis as well as cell proliferation in many tissues. In particular, it has been demonstrated that insulin stimulates both proliferation of vascular smooth cells and cardiomyocyte hypertrophy by increasing mRNA levels for muscle-specific genes (myosin light chain, O-actin, and troponin I) and stimulating protein synthesis.
Therefore, it is plausible that hyperinsulinemia in hypertension could stimulate SNS activity, which may, in turn, affect ventricular structure directly, due to growth-stimulating effects, or, indirectly, by contributing to increases in heart rate and blood pressure levels.
However, further studies are required in order to demonstrate the association between IR, compensatory hyperinsulinemia, and alteration in cardiovascular structure.
| Conclusion|| |
The increased insulin levels and the HOMA index appear, at least in part, to mediate the concentric LV geometry in hypertensive patients.
Hence, the present results indicate that measurement of serum insulin levels and calculation of the HOMA index could provide a clue into the pathogenesis of different LV geometries in patients with mild-to-moderate EH.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS, et al.
The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992;117:831-6.
Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al.
Hyperinsulinemia as an independent risk factor for ischemic heart disease. N
Engl J Med 1996;334:952-7.
Kaftan HA, Evrengul H, Tanriverdi H, Kilic M. Effect of insulin resistance on left ventricular structural changes in hypertensive patients. Int Heart J 2006;47:391-400.
Persic V, Ruzic A, Miletic B, Balen S, Jovanovic Z, Vcev A, et al.
Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension. Wien Klin Wochenschr 2007;119:423-7.
Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: The Framingham Heart Study. Hypertension 1997;30:1025-8.
Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol 1991;17:717-21.
Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S, et al.
Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab 1998;83:4284-8.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, et al.
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al.
Guidelines for performing a comprehensive transesophageal echocardiographic examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2013;26:921-64.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al.
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.
Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, Telera MP, et al.
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999;100:1802-7.
Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, et al.
Associations of insulin levels with left ventricular structure and function in American Indians: The strong heart study. Diabetes 2002;51:1543-7.
Malmqvist K, Kahan T, Isaksson H, Ostergren J. Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism. Blood Press 2001;10:101-10.
Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol 1995;25:879-84.
Holmäng A, Yoshida N, Jennische E, Waldenström A, Björntorp P. The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats. Eur J Clin Invest 1996;26:973-8.
Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – The role of insulin resistance and the sympathoadrenal system. N
Engl J Med 1996;334:374-81.
Di Bello V, Santini F, Di Cori A, Pucci A, Palagi C, Delle Donne MG, et al.
Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: A color Doppler imaging study. Int J Obes (Lond) 2006;30:948-56.
Masliza M, Daud SM, Khalid Y. 2005 Young investigator's award winner: Assessment of diastolic function in newly diagnosed hypertensives. Ann Acad Med Singapore 2005;34:684-5.
Paolisso G, Galderisi M, Tagliamonte MR, de Divitis M, Galzerano D, Petrocelli A, et al.
Myocardial wall thickness and left ventricular geometry in hypertensives. Relationship with insulin. Am J Hypertens 1997;10:1250-6.
Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, et al.
Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-21.
[Table 1], [Table 2], [Table 3], [Table 4]